Fixed Price IPO | ₹18 Cr | Listed at NSE SME | Thu, Aug 25, 2022 - Tue, Aug 30, 2022
JFL Life Sciences IPO is a fixed price issue of ₹18.17 crores. The issue is entirely a fresh issue of 0.30 crore shares of ₹18.17 crore.
JFL Life Sciences IPO bidding started from Aug 25, 2022 and ended on Aug 30, 2022. The allotment for JFL Life Sciences IPO was finalized on Sep 5, 2022. The shares got listed on NSE SME on Sep 8, 2022.
JFL Life Sciences IPO price is ₹61 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,22,000 (2000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (4,000 shares), amounting to ₹2,44,000.
GYR Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Econo Broking Pvt.Ltd..
Refer to JFL Life Sciences IPO RHP for detailed Information.
IPO Open
Thu, Aug 25, 2022
IPO Close
Tue, Aug 30, 2022
Issue Price
₹61 per share
Market Cap (Pre-IPO)
₹67.09 Cr
| IPO Date | 25 to 30 Aug, 2022 |
| Listed on | Thu, Sep 8, 2022 |
| Face Value | ₹10 per share |
| Issue Price | ₹61 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Total Issue Size | 29,78,000 shares (agg. up to ₹18 Cr) |
| Reserved for Market Maker | 1,50,000 shares Econo Broking Pvt.Ltd. (agg. up to ₹0.9150 Cr) |
| Fresh Issue (Ex Market Maker) | 28,28,000 shares (agg. up to ₹17 Cr) |
| Net Offered to Public | 28,28,000 shares (agg. up to ₹17 Cr) |
| Share Holding Pre Issue | 80,20,441 shares |
| Share Holding Post Issue | 1,09,98,441 shares |
| NSE Symbol | JFLLIFE |
| ISIN | INE0LA901015 |
JFL Life Sciences IPO comprises a total issue size of 29,78,000 shares. The net offer to the public is 28,28,000 shares, after excluding 1,50,000 shares allotted on a firm basis. Of the Net offer 14,14,000 (50.00%) allocated to NII 14,14,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 14,14,000 | 50.00% | 47.48% |
| Retail Shares Offered | 14,14,000 | 50.00% | 47.48% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,50,000 | 5.04% | |
| Total Shares Offered | 29,78,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 2,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,22,000 |
| Retail (Max) | 1 | 2,000 | ₹1,22,000 |
| HNI (Min) | 2 | 4,000 | ₹2,44,000 |
Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
JFL has two manufacturing units (on lease) in Gujarat.
Competitive Strength :
| Period Ended | 28 Feb 2022 | 31 Mar 2021 | 31 Mar 2020 | 31 Aug 2019 |
|---|---|---|---|---|
| Assets | 36.63 | 29.01 | 24.33 | 16.15 |
| Total Income | 25.63 | 32.87 | 30.20 | 31.78 |
| Profit After Tax | 2.53 | 0.54 | 0.36 | 0.30 |
| NET Worth | 10.97 | 6.87 | 5.38 | 5.01 |
| Reserves and Surplus | 2.94 | 6.38 | 4.95 | 4.59 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment of secured and unsecured loans | 7.50 |
| 2 | Funding the working capital requirements of the company | 6.00 |
| 3 | General Corporate Purposes | 4.27 |
| KPI | |
|---|---|
| RoNW | 7.89% |
| PAT Margin | 1.65% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 0.89 | |
| P/E (x) | 26.52 | |
| Promoter Holding | 92.52% | 67.47% |
| Market Cap | ₹67.09 Cr. |
The JFL Life Sciences IPO is subscribed 8.93 times on August 30, 2022 5:00:00 PM (Day 4). The public issue subscribed 11.66 times in the retail category, [.] times in the QIB category, and 6.19 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 6.19 | 14,14,000 | 87,58,000 |
| Retail | 11.66 | 14,14,000 | 1,64,84,000 |
| Total | 8.93 | 28,28,000 | 2,52,42,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Issue Management fees including Merchant Banking fees and Market Making fees, Underwriting fees and payment to other intermediaries such as Legal Advisors, Registrars and other out of pocket expenses | 0.29 |
| 2 | Advertising and Marketing Expenses | 0.02 |
| 3 | Fees payable to the to the Regulators including stock exchange(s) | 0.07 |
| 4 | Printing & Stationery, Distribution, Postage, etc. | 0.01 |
| 5 | Brokerage and selling commission | 0.01 |
| 6 | Other Expenses (Banker’s to the Issue, Auditor’s fees etc.) | 0.02 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹61.00 |
| Open | ₹70.00 |
| Low | ₹66.50 |
| High | ₹70.00 |
| Last Trade | ₹66.50 |
Lead Manager Reports
JFL Life Sciences IPO is a SME IPO of 29,78,000 equity shares of the face value of ₹10 aggregating up to ₹18 Crores. The issue is priced at ₹61 per share. The minimum order quantity is 2000.
The IPO opens on Thu, Aug 25, 2022, and closes on Tue, Aug 30, 2022.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in JFL Life Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in JFL Life Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in JFL Life Sciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The JFL Life Sciences IPO opens on Thu, Aug 25, 2022 and closes on Tue, Aug 30, 2022.
JFL Life Sciences IPO lot size is 2000, and the minimum amount required for application is ₹1,22,000.
You can apply in JFL Life Sciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for JFL Life Sciences IPO will be done on Monday, September 5, 2022, and the allotted shares will be credited to your demat account by Wed, Sep 7, 2022. Check the JFL Life Sciences IPO allotment status.
The JFL Life Sciences IPO listing date is on Thu, Sep 8, 2022.
